Study population
This post-hoc analysis was based on a multi-centre, double-blind, randomized, and controlled phase 3 trial (ClinicalTrials.gov: NCT01735006) of an The trial was approved by the Independent Ethics Committee. Written informed consent was obtained from each participant, and the study was done in accordance with the principles of the Declaration of Helsinki, the standards of Good Clinical Practice, and Chinese regulatory requirements.